Overview

Gilead Sciences, Inc. is a biopharmaceutical company that is focused on advancing medicines to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis...

Open

$0.00

Prior close

$150.89

Today's high

$0.00

Today's low

$0.00

52 Week high

$157.29

52 Week low

$108.46

News

Business Wire • 1 day ago • GILD

Latin America's PAHO-Gilead HIV Prevention Deal Is a Victory for Civil Society, says AHF

Zacks Investment Research • 1 day ago • GILD

Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know

Zacks Investment Research • 2 days ago • GILD

Gilead Expands Lenacapavir Access With New PAHO Deal in Latin America

Business Wire • 2 days ago • GILD

Gilead Accelerates Global Access Planning for Investigational Once-Yearly Lenacapavir for HIV Prevention

MarketBeat • 3 days ago • GILD

Gilead Sciences Sees Yeztugo Powering HIV Growth as Oncology Pipeline Advances